BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 8327467)

  • 1. A kinetic model for amyloid formation in the prion diseases: importance of seeding.
    Come JH; Fraser PE; Lansbury PT
    Proc Natl Acad Sci U S A; 1993 Jul; 90(13):5959-63. PubMed ID: 8327467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PrP aggregation can be seeded by pre-formed recombinant PrP amyloid fibrils without the replication of infectious prions.
    Barron RM; King D; Jeffrey M; McGovern G; Agarwal S; Gill AC; Piccardo P
    Acta Neuropathol; 2016 Oct; 132(4):611-24. PubMed ID: 27376534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Self-Replication of Prion Protein Fragment 89-230 Amyloid Fibrils Accelerated by Prion Protein Fragment 107-143 Aggregates.
    Sneideris T; Ziaunys M; Chu BK; Chen RP; Smirnovas V
    Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33049945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PrP P102L and Nearby Lysine Mutations Promote Spontaneous
    Kraus A; Raymond GJ; Race B; Campbell KJ; Hughson AG; Anson KJ; Raymond LD; Caughey B
    J Virol; 2017 Nov; 91(21):. PubMed ID: 28835493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dissociation of prion protein amyloid seeding from transmission of a spongiform encephalopathy.
    Piccardo P; King D; Telling G; Manson JC; Barron RM
    J Virol; 2013 Nov; 87(22):12349-56. PubMed ID: 24027305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The seeding barrier between human and Syrian hamster prion protein amyloid fibrils is determined by β2-α2 loop sequence elements.
    Šulskis D; Šneiderienė G; Žiaunys M; Smirnovas V
    Int J Biol Macromol; 2023 May; 238():124038. PubMed ID: 36921824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prion protein misfolding and disease.
    Moore RA; Taubner LM; Priola SA
    Curr Opin Struct Biol; 2009 Feb; 19(1):14-22. PubMed ID: 19157856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Species-barrier phenomenon in prion transmissibility from a viewpoint of protein science.
    Hagiwara K; Hara H; Hanada K
    J Biochem; 2013 Feb; 153(2):139-45. PubMed ID: 23284000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of misfolding of the human prion protein revealed by a pathological mutation.
    Sanz-Hernández M; Barritt JD; Sobek J; Hornemann S; Aguzzi A; De Simone A
    Proc Natl Acad Sci U S A; 2021 Mar; 118(12):. PubMed ID: 33731477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Critical region for amyloid fibril formation of mouse prion protein: unusual amyloidogenic properties of the helix 2 peptide.
    Yamaguchi K; Matsumoto T; Kuwata K
    Biochemistry; 2008 Dec; 47(50):13242-51. PubMed ID: 19053276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amyloid in Alzheimer's disease and prion-related encephalopathies: studies with synthetic peptides.
    Forloni G; Tagliavini F; Bugiani O; Salmona M
    Prog Neurobiol; 1996 Jul; 49(4):287-315. PubMed ID: 8888112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of prion peptide structure and aggregation in toxicity and membrane binding.
    Rymer DL; Good TA
    J Neurochem; 2000 Dec; 75(6):2536-45. PubMed ID: 11080207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro evaluation of the anti-prionic activity of newly synthesized congo red derivatives.
    Poli G; Ponti W; Carcassola G; Ceciliani F; Colombo L; Dall'Ara P; Gervasoni M; Giannino ML; Martino PA; Pollera C; Villa S; Salmona M
    Arzneimittelforschung; 2003; 53(12):875-88. PubMed ID: 14750496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amyloids, prions and the inherent infectious nature of misfolded protein aggregates.
    Soto C; Estrada L; Castilla J
    Trends Biochem Sci; 2006 Mar; 31(3):150-5. PubMed ID: 16473510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defining and Assessing Analytical Performance Criteria for Transmissible Spongiform Encephalopathy-Detecting Amyloid Seeding Assays.
    Gray JG; Graham C; Dudas S; Paxman E; Vuong B; Czub S
    J Mol Diagn; 2016 May; 18(3):454-467. PubMed ID: 27068712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transmission and Replication of Prions.
    Marín-Moreno A; Fernández-Borges N; Espinosa JC; Andréoletti O; Torres JM
    Prog Mol Biol Transl Sci; 2017; 150():181-201. PubMed ID: 28838661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease.
    Jarrett JT; Berger EP; Lansbury PT
    Biochemistry; 1993 May; 32(18):4693-7. PubMed ID: 8490014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two-rung model of a left-handed beta-helix for prions explains species barrier and strain variation in transmissible spongiform encephalopathies.
    Langedijk JP; Fuentes G; Boshuizen R; Bonvin AM
    J Mol Biol; 2006 Jul; 360(4):907-20. PubMed ID: 16782127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amyloid formation by recombinant full-length prion proteins in phospholipid bicelle solutions.
    Lührs T; Zahn R; Wüthrich K
    J Mol Biol; 2006 Mar; 357(3):833-41. PubMed ID: 16466741
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Eraña H; Fernández-Borges N; Elezgarai SR; Harrathi C; Charco JM; Chianini F; Dagleish MP; Ortega G; Millet Ó; Castilla J
    J Virol; 2017 Dec; 91(24):. PubMed ID: 28978705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.